These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18772353)

  • 1. Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.
    Jahnke K; Muldoon LL; Varallyay CG; Lewin SJ; Kraemer DF; Neuwelt EA
    Neuro Oncol; 2009 Apr; 11(2):142-50. PubMed ID: 18772353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.
    Muldoon LL; Gahramanov S; Li X; Marshall DJ; Kraemer DF; Neuwelt EA
    Neuro Oncol; 2011 Jan; 13(1):51-60. PubMed ID: 21123368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antitumor effect of carboplatin delivered by intracerebral microinfusion in a rat malignant glioma model.
    Tange Y; Miyazaki M; Iwata J; Aiko Y; Sakamoto S; Mori K
    Neurol Med Chir (Tokyo); 2009 Dec; 49(12):572-9. PubMed ID: 20035131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with bevacizumab plus carboplatin for recurrent malignant glioma.
    Thompson EM; Dosa E; Kraemer DF; Neuwelt EA
    Neurosurgery; 2010 Jul; 67(1):87-93. PubMed ID: 20559095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
    Desjardins A; Reardon DA; Herndon JE; Marcello J; Quinn JA; Rich JN; Sathornsumetee S; Gururangan S; Sampson J; Bailey L; Bigner DD; Friedman AH; Friedman HS; Vredenburgh JJ
    Clin Cancer Res; 2008 Nov; 14(21):7068-73. PubMed ID: 18981004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
    Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
    Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
    Varallyay CG; Muldoon LL; Gahramanov S; Wu YJ; Goodman JA; Li X; Pike MM; Neuwelt EA
    J Cereb Blood Flow Metab; 2009 Apr; 29(4):853-60. PubMed ID: 19142191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors.
    Bokstein F; Shpigel S; Blumenthal DT
    Cancer; 2008 May; 112(10):2267-73. PubMed ID: 18327820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma.
    Verhoeff JJC; Lavini C; van Linde ME; Stalpers LJA; Majoie CBLM; Reijneveld JC; van Furth WR; Richel DJ
    Ann Oncol; 2010 Aug; 21(8):1723-1727. PubMed ID: 20064829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.
    Kaloshi G; Diamandi P; Cakani B; Brace G; Rroji A; Petrela M
    Tumori; 2015; 101(1):41-5. PubMed ID: 25702676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer.
    Shah DK; Veith J; Bernacki RJ; Balthasar JP
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):951-8. PubMed ID: 21305289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
    Leone JP; Emblem KE; Weitz M; Gelman RS; Schneider BP; Freedman RA; Younger J; Pinho MC; Sorensen AG; Gerstner ER; Harris G; Krop IE; Morganstern D; Sohl J; Hu J; Kasparian E; Winer EP; Lin NU
    Breast Cancer Res; 2020 Nov; 22(1):131. PubMed ID: 33256829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
    Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
    Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab is active as a single agent against recurrent malignant gliomas.
    Agha CA; Ibrahim S; Hassan A; Elias DA; Fathallah-Shaykh HM
    Anticancer Res; 2010 Feb; 30(2):609-11. PubMed ID: 20332478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
    Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
    Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.
    Cha S; Knopp EA; Johnson G; Litt A; Glass J; Gruber ML; Lu S; Zagzag D
    AJNR Am J Neuroradiol; 2000 May; 21(5):881-90. PubMed ID: 10815664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
    Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CS; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; ; Rosenthal MA
    Neuro Oncol; 2015 Nov; 17(11):1504-13. PubMed ID: 26130744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.